Stockreport

FDA signs off in NantKwest IND for cell therapy for ARDS [Seeking Alpha]

NANTKWEST  (NK) 
Last nantkwest earnings: 3/25 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nantkwest.com
PDF The FDA has OK'd NantKwest's (NK+5.5%evaluatingThe 45-subject study will assess the product versus standard supporting care in severely ill patients requiring mechanical [Read more]